| 000 | 01732 a2200589 4500 | ||
|---|---|---|---|
| 005 | 20250517221351.0 | ||
| 264 | 0 | _c20190403 | |
| 008 | 201904s 0 0 eng d | ||
| 022 | _a1468-1331 | ||
| 024 | 7 |
_a10.1111/ene.13694 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFrau, J | |
| 245 | 0 | 0 |
_aClinical activity after fingolimod cessation: disease reactivation or rebound? _h[electronic resource] |
| 260 |
_bEuropean journal of neurology _c10 2018 |
||
| 300 |
_a1270-1275 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFingolimod Hydrochloride _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
| 650 | 0 | 4 | _aItaly |
| 650 | 0 | 4 | _aMagnetic Resonance Imaging |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMultiple Sclerosis, Relapsing-Remitting _xdiagnostic imaging |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aWithholding Treatment |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aSormani, M P | |
| 700 | 1 | _aSignori, A | |
| 700 | 1 | _aRealmuto, S | |
| 700 | 1 | _aBaroncini, D | |
| 700 | 1 | _aAnnovazzi, P | |
| 700 | 1 | _aSignoriello, E | |
| 700 | 1 | _aManiscalco, G T | |
| 700 | 1 | _aLa Gioia, S | |
| 700 | 1 | _aCordioli, C | |
| 700 | 1 | _aFrigeni, B | |
| 700 | 1 | _aRasia, S | |
| 700 | 1 | _aFenu, G | |
| 700 | 1 | _aGrasso, R | |
| 700 | 1 | _aSartori, A | |
| 700 | 1 | _aLanzillo, R | |
| 700 | 1 | _aStromillo, M L | |
| 700 | 1 | _aRossi, S | |
| 700 | 1 | _aForci, B | |
| 700 | 1 | _aCocco, E | |
| 773 | 0 |
_tEuropean journal of neurology _gvol. 25 _gno. 10 _gp. 1270-1275 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/ene.13694 _zAvailable from publisher's website |
| 999 |
_c28480151 _d28480151 |
||